The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy

UK Collaborative HIV Cohort (CHIC) Study, C A Sabin, C J Smith, V Delpech, J Anderson, L Bansi, R Gilson, A Schwenk, C Leen, B Gazzard, K Porter, N Mackie, M Fisher, C Orkin, M Johnson, P Easterbrook, T Hill, A N Phillips

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of this study was to describe the relationship between age and the time to treatment discontinuation in the absence of virological failure as well as the development of specific laboratory abnormalities, in patients starting highly active antiretroviral therapy (HAART) for the first time.
Original languageEnglish
Pages (from-to)35-43
Number of pages9
JournalHIV Medicine
Volume10
Issue number1
DOIs
Publication statusPublished - Jan 2009

Keywords

  • Adult
  • Age Factors
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Drug Administration Schedule
  • Female
  • HIV Infections
  • HIV-1
  • Humans
  • Male
  • Middle Aged
  • Patient Compliance
  • Time Factors
  • Viral Load

Fingerprint

Dive into the research topics of 'The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy'. Together they form a unique fingerprint.

Cite this